Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the parent study is to assess the short-term safety and tolerability of
soluble ferric pyrophosphate (SFP) in dialysate administered to a large number of
representative adult chronic kidney disease patients on hemodialysis (CKD-HD).
The purpose of the extension study is to assess the long-term safety and tolerability of SFP.